品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | B113757-1g | 1g | 期货,请咨询 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzyl-4-hydroxypiperidine |
≥97% |
|
|
阿拉丁 | B113757-5g | 5g | 期货,请咨询 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzyl-4-hydroxypiperidine |
≥97% |
|
|
阿拉丁 | B113757-25g | 25g | 期货,请咨询 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzyl-4-hydroxypiperidine |
≥97% |
|
|
麦克林 | B802951-5g | 5g | 订前询问 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzyl-4-hydroxypiperidine |
0.97 |
|
|
麦克林 | B802951-25g | 25g | 订前询问 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzyl-4-hydroxypiperidine |
0.97 |
|
|
麦克林 | B802951-1g | 1g | 订前询问 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzyl-4-hydroxypiperidine |
0.97 |
|
|
罗恩 | R030724-1g | 1g | 5~7个工作日 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzyl-4-hydroxypiperidine |
97% |
|
|
罗恩 | R030724-25g | 25g | 5~7个工作日 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzyl-4-hydroxypiperidine |
97% |
|
|
罗恩 | R030724-5g | 5g | 5~7个工作日 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzyl-4-hydroxypiperidine |
97% |
|
|
MARY | MR141835-1g | 1g | 订前咨询 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzyl-4-hydroxypiperidine |
97% |
|
|
MARY | MR141835-25g | 25g | 订前咨询 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzyl-4-hydroxypiperidine |
97% |
|
|
MARY | MR141835-5g | 5g | 订前咨询 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzyl-4-hydroxypiperidine |
97% |
|
|
韶远 | SY010009-1g | 1g | 现货 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzyl-4-hydroxypiperidine |
≥95% |
|
|
阿法埃莎 | A15664-1g | 1g | 现货 | 51135-96-7 |
4-苄基-4-羟基哌啶, 97% 4-Benzyl-4-hydroxypiperidine... |
97% |
|
|
阿法埃莎 | A15664-5g | 5g | 现货 | 51135-96-7 |
4-苄基-4-羟基哌啶, 97% 4-Benzyl-4-hydroxypiperidine... |
97% |
|
|
阿法埃莎 | A15664-25g | 25g | 现货 | 51135-96-7 |
4-苄基-4-羟基哌啶, 97% 4-Benzyl-4-hydroxypiperidine... |
97% |
|
|
毕得 | BD94412-1g | 1g | 现货 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzylpiperidin-4-ol |
97% |
|
|
毕得 | BD94412-5g | 5g | 现货 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzylpiperidin-4-ol |
97% |
|
|
毕得 | BD94412-100mg | 100mg | 现货 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzylpiperidin-4-ol |
97% |
|
|
毕得 | BD94412-250mg | 250mg | 现货 | 51135-96-7 |
4-苄基-4-羟基哌啶 4-Benzylpiperidin-4-ol |
97% |
|
|